longterm56 wrote: Does the statement "The global market for drugs to treat NASH is expected to reach $84 billion by 2029" mean ...
a) in 2029 the annual sales will be $84B?
b) between now and 2029 the cumulative sales will total $84B?
Thanks -
-LT
quote=scarlet1967]
Oramed's Phase 2 Oral Insulin NASH Trial Reaches Over 50% Enrollment - Oramed Pharmaceuticals
Oramed's Phase 2 Oral Insulin NASH Trial Reaches Over 50% Enrollment - Oramed Pharmaceuticals
Oramed Reaches 25% Enrollment in Its Second of Two Concurrent Phase 3 Oral Insulin Trials - Oramed Pharmaceuticals
“The global market for drugs to treat NASH is expected to reach $84 billion by 2029.”
This is one way to spread the news.
This company seems to be developing mostly oral drugs for diabetes type 1/2 and patients suffering from both diabetes and NASH. Looking through their PRs there were some mentioning of Covid Vaccin. The company and Premas Biotech created a new company Oravax (preclinical covid so far). In the past 12 months their valuation has appreciated by 670%.
Over 4000 followers on Stocktwits, valuation over $660M, over 800k daily volume.
Point is there are no norms re how to spread the news. THTX has an open label cancer trial yet they don’t know anything about it’s progress as per the chat with Ed Nash?Their progresses with regulators for NASH seems to be handled by the secret service until now they are trying to bring it back to spot lights! Shares are currently“ridiculously cheap” for a good reason and the reason is…